Purchase Order HHSN269201700679P
Award Date 9/6/17
Potential Completion Date 9/5/18
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...
- This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
- This federal contract award, valued at $11,170.80, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which is not set aside for small businesses, is for the provision of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various government agencies, particularly within the Department of...
- Stemcell Technologies Inc., a Canadian biotechnology company, was awarded a $7,485 firm-fixed-price purchase order contract (HHSN272201100756P) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, which does not have a small business set-aside, was awarded on August 10, 2011 with a completion date of July 30, 2012. Stemcell Technologies Inc. primarily...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company, to provide specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research initiatives across various government agencies. The contract, valued at...
- This is a $18,772.80 firm fixed-price purchase order awarded to Stemcell Technologies Inc. by the National Institutes of Health (NIH) Clinical Center on November 13, 2024. Stemcell Technologies Inc. is a subsidiary of the Canadian biotechnology company Stemcell Technologies. This contract is not set aside for small businesses. The award provides specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $84,089.26 contract is for the provision of specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research across various NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases,...
- Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
- This is a $10,125.00 firm-fixed-price purchase order contract awarded to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services. The contract is for the supply of laboratory supplies to support NICHD's biomedical research initiatives. Stemcell Technologies Inc. is a key supplier to federal research institutions, particularly...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...